Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1988 1
1989 1
1995 1
1996 1
1999 1
2001 2
2008 1
2010 1
2011 1
2013 3
2014 1
2015 2
2017 1
2018 1
2019 1
2020 2
2022 4
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma.
Westin JR, Oluwole OO, Kersten MJ, Miklos DB, Perales MA, Ghobadi A, Rapoport AP, Sureda A, Jacobson CA, Farooq U, van Meerten T, Ulrickson M, Elsawy M, Leslie LA, Chaganti S, Dickinson M, Dorritie K, Reagan PM, McGuirk J, Song KW, Riedell PA, Minnema MC, Yang Y, Vardhanabhuti S, Filosto S, Cheng P, Shahani SA, Schupp M, To C, Locke FL; ZUMA-7 Investigators; Kite Members. Westin JR, et al. N Engl J Med. 2023 Jul 13;389(2):148-157. doi: 10.1056/NEJMoa2301665. Epub 2023 Jun 5. N Engl J Med. 2023. PMID: 37272527 Clinical Trial.
Food and Nutrition Security Theory.
Simelane KS, Worth S. Simelane KS, et al. Among authors: worth s. Food Nutr Bull. 2020 Sep;41(3):367-379. doi: 10.1177/0379572120925341. Food Nutr Bull. 2020. PMID: 33200627
Opioid Use Disorder: Treatment & Recovery.
Worth S, House K. Worth S, et al. N C Med J. 2018 May-Jun;79(3):185-187. doi: 10.18043/ncm.79.3.185. N C Med J. 2018. PMID: 29735626 Free article.
Post-remission cytopenia management in patients with AML treated with venetoclax in combination with hypomethylating agents: Pre- versus post-VIALE-A real-world experience from a predominantly US community setting.
Vachhani P, Ma E, Xu T, Montez M, Worth S, Yellow-Duke A, Cheng WH, Werner ME, Abbas J, Donnellan W. Vachhani P, et al. Among authors: worth s. Cancer Med. 2023 Sep;12(17):17914-17923. doi: 10.1002/cam4.6430. Epub 2023 Aug 11. Cancer Med. 2023. PMID: 37568276 Free PMC article.
Everyday action planning in schizophrenia.
Seter C, Giovannetti T, Kessler RK, Worth S. Seter C, et al. Among authors: worth s. Neuropsychol Rehabil. 2011 Apr;21(2):224-49. doi: 10.1080/09602011.2010.544519. Epub 2011 Feb 2. Neuropsychol Rehabil. 2011. PMID: 21294047 Clinical Trial.
Dismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.
Zainaldin C, Arora S, Bathini S, Gupta U, Pandya V, Bae S, Worth S, Bachiashvili K, Bhatia R, Godby K, Jamy O, Rangaraju S, Diamond B, Oliver JD, Salzman D, Di Stasi A, Vachhani P. Zainaldin C, et al. Among authors: worth s. Leuk Lymphoma. 2022 Dec;63(13):3245-3248. doi: 10.1080/10428194.2022.2113530. Epub 2022 Sep 15. Leuk Lymphoma. 2022. PMID: 36107006 No abstract available.
34 results